Market Overview

Canaccord Genuity Initiates Histogenics With Buy


Analysts at Canaccord Genuity initiated coverage on Histogenics Corporation (NASDAQ: HSGX) with a Buy rating.

The target price for Histogenics is set to $16.50.

Histogenics' shares rose 0.45% to close at $11.05 on Friday.

Latest Ratings for HSGX

Dec 2018DowngradesBuyNeutral
Sep 2018DowngradesBuyNeutral
Dec 2016Initiates Coverage OnBuy

View More Analyst Ratings for HSGX
View the Latest Analyst Ratings

Posted-In: Canaccord GenuityInitiation Analyst Ratings


Related Articles (HSGX)

View Comments and Join the Discussion!

Latest Ratings

GPKDeutsche BankMaintains17.0
TRUDeutsche BankMaintains85.0
HADeutsche BankMaintains28.0
NOWDeutsche BankMaintains260.0
CNCDeutsche BankMaintains60.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Roth Capital Initiates Pacific Ethanol At Buy

UPDATE: Bank Of America Upgrades Treehouse Foods As Coverage Is Transferred